A liquid biopsy is a minimally invasive test that detects cancer biomarkers, such as DNA, RNA, or proteins, in body fluids like blood. It offers several advantages over traditional tissue biopsies, including reduced risk, ease of repeat testing, and the ability to monitor treatment response and detect recurrence early.
